EverSource Wealth Advisors LLC Grows Position in UnitedHealth Group Incorporated $UNH

EverSource Wealth Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 48.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,790 shares of the healthcare conglomerate’s stock after purchasing an additional 1,901 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,806,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its holdings in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC lifted its position in UnitedHealth Group by 3.3% during the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock valued at $6,624,411,000 after buying an additional 675,075 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group in the second quarter worth $3,837,207,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 6.1% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 7,502,469 shares of the healthcare conglomerate’s stock valued at $2,340,346,000 after acquiring an additional 432,084 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at $3,846,764,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. Mizuho upped their target price on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price objective for the company. Barclays upped their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Piper Sandler cut their price objective on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday, October 28th. Finally, UBS Group lifted their target price on UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Seventeen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Hold” and a consensus target price of $385.54.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $333.81 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock has a market capitalization of $302.38 billion, a price-to-earnings ratio of 17.42, a PEG ratio of 2.22 and a beta of 0.43. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $608.99. The company’s 50-day simple moving average is $342.06 and its 200-day simple moving average is $315.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the business posted $7.15 EPS. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.